Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-02

Clinical Trial Update: Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy and safety of Anaferon for acute respiratory viral infections has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anaferon

Snippet

Sponsor: Materia Medica Holding | Conditions: Acute Respiratory Viral Infections | Phase 4 | Status: COMPLETED | Results posted: 2020-09-02